Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 344.74M P/E - EPS this Y - Ern Qtrly Grth -
Income -44.02M Forward P/E -8.04 EPS next Y - 50D Avg Chg 8.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 69.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -25.00%
Recommedations 3.00 Quick Ratio 4.39 Shares Outstanding 61.29M 52W Low Chg 514.00%
Insider Own 72.20% ROA -50.06% Shares Float 17.01M Beta 1.75
Inst Own 7.99% ROE -100.65% Shares Shorted/Prior 2.75M/2.94M Price 7.24
Gross Margin - Profit Margin - Avg. Volume 145,532 Target Price -
Oper. Margin - Earnings Date Nov 11 Volume 125,637 Change -1.50%
About Pulse Biosciences, Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Pulse Biosciences, Inc News
12/19/24 Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
12/17/24 Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
12/16/24 Robert Duggan Spends US$972k On Pulse Biosciences Stock
12/12/24 Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop
11/15/24 Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans
10/31/24 Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
10/31/24 Q3 2024 Pulse Biosciences Inc Earnings Call
10/31/24 Pulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
10/30/24 Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
10/30/24 Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology
10/21/24 Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024
08/21/24 Better Cotton Pakistan, PULSE to boost data transparency in cotton farming
08/13/24 Q2 2024 Pulse Biosciences Inc Earnings Call
08/12/24 Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
08/12/24 Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors
08/09/24 Pulse Biosciences launches first-in-human pulsed field ablation trial
08/08/24 Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
08/01/24 Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
07/29/24 Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
07/09/24 Pulse drops 510(k) plan for PFA device after FDA requests clinical data
PLSE Chatroom

User Image TruthBroker2 Posted - 2 days ago

$PLSE

User Image liloleme4 Posted - 3 days ago

$PLSE In turbulent gov't times, I'm going to continue following Duggan... HAYWARD, Calif. --(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced that, on December 18, 2024 , the Company’s Co-Chairman and majority shareholder, Robert W. Duggan , exercised all of the warrants he acquired in the Company’s 2024 rights offering, corresponding to $58.4 million totaling to 5,306,156 shares of Company common stock. Mr. Duggan also confirmed that, from December 11, 2024 through this past Friday, December 13, 2024 , he has purchased an additional 156,714 shares of Pulse Biosciences . These transactions bring Mr. Duggan’s current ownership in the Company to approximately 70%.

User Image GI197845 Posted - 3 days ago

$PLSE Question- How do you guys think a Trump administration would affect pharma stocks? Would Trump make the pharma stocks go up or down? Or would it be a mix?I know PLSE is not exactly pharma, it's a Biotech-biomed of sorts, but that is still healthcare related. I saw an article posted on Becker's hospital review that Trump wants to eliminate the middle man and maybe that's a good thing to bring drug/healthcare costs down? But, doesn't that mean less pharma profits for investors? Could eliminating the middle man lower drug costs, but increase pharma and pharma stock profits because more people could afford the drugs or some other reason? I wonder how orphan drugs costs and profits to treat rare conditions would be affected? Are we invested in the wrong sector for a Trump, RFK jr., Elon and Vivek Admin? Would it be best to be invested in A.I. and oil for a Trump Admin?

User Image TruthBroker2 Posted - 5 days ago

$PLSE More Good News 👍

User Image TruthBroker2 Posted - 5 days ago

$PLSE Gonna be good Christmas 25 Lfggg

User Image liloleme4 Posted - 5 days ago

$PLSE With Schwab buying in and Duggan adding another 56+K shares on 12/11 (giving him 70+% ownership now), 'tis not surprising to see a nice increase here. I assume someone else (large) is taking a position too. Liloleme is riding coattails like I usually do... fortunately, having bought lower than the current price

User Image MaverikIT Posted - 5 days ago

@IsabellaDC @net0trader $PLSE +2.53 - getting pulse$$$

User Image TruthBroker2 Posted - 5 days ago

$PLSE

User Image Briguy1 Posted - 6 days ago

$PLSE https://www.marketbeat.com/instant-alerts/charles-schwab-investment-management-inc-has-260-million-stake-in-pulse-biosciences-inc-nasdaqplse-2024-12-16/#google_vignette

User Image LeisureSuitLarry Posted - 1 week ago

@TruthBroker2 he needs some $PLSE

User Image TruthBroker2 Posted - 1 week ago

$PLSE

User Image TruthBroker2 Posted - 1 week ago

$PLSE

User Image twib Posted - 1 week ago

$PLSE just putting this out there! https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.stocktitan.net/news/SLS/sellas-announces-positive-overall-survival-and-overall-response-rate-40txed5b9am8.html&ved=2ahUKEwiG0cLNnpyKAxXllYkEHXMiFuEQFnoECAUQAQ&usg=AOvVaw12ZVI_rc-DoX_5pKeO3fyV

User Image TruthBroker2 Posted - 2 weeks ago

$PLSE $SMMT

User Image investhedge Posted - 2 weeks ago

$MCRB I’ve heard this many times in the past, Check out $SMMT and $PLSE , thereafter I’ll give you some more names, doesn’t happen a lot but once they go -they go hard and relatively quick

User Image TruthBroker2 Posted - 2 weeks ago

$PLSE Green Monday

User Image Doozio Posted - 11/29/24

This bum has a $plse again TTWO? Tough to TRAK them all INTA 🧠⏰♾️

User Image Shlobby Posted - 11/29/24

$PLSE MAs lookin like they about to go vertical

User Image JazzyJ03 Posted - 11/29/24

$PLSE Long!

User Image TruthBroker2 Posted - 11/29/24

$PLSE 52 Week HIGH Incoming

User Image TruthBroker2 Posted - 11/29/24

$PLSE Green Friday

User Image TruthBroker2 Posted - 11/27/24

$PLSE

User Image liloleme4 Posted - 11/26/24

$PLSE Due to being asked... here's what was on my Schwab notifications: 02:47 PM EST, 11/26/2024 (MT Newswires) -- Pulse Biosciences (PLSE) shares rose 15% in recent Tuesday trading after board Co-Chairman Robert Duggan, the controlling stockholder, informed management he may increase his stake in the company. Duggan has until Dec. 10 to purchase up to 500,000 shares, Pulse Biosciences said Tuesday in a regulatory filing. Price: 20.69, Change: +2.70, Percent Change: +15.08 http://www.mtnewswires.com Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice.

User Image liloleme4 Posted - 11/26/24

$PLSE Duggan has until Dec 10th to buy up to 500k shares more. That explains today's increase in case anyone else was wondering - not like there are tons of readers here on a daily basis. I've enjoyed the rise, esp having bought some dips

User Image TruthBroker2 Posted - 11/26/24

$PLSE Baker Brother$ get in ?

User Image TruthBroker2 Posted - 11/26/24

$SMMT $PLSE

User Image TruthBroker2 Posted - 11/25/24

$PLSE $SMMT Genius

User Image TruthBroker2 Posted - 1 month ago

$PLSE Ok 50 Next Year

User Image TruthBroker2 Posted - 1 month ago

$PLSE 20+ LFG

User Image TruthBroker2 Posted - 1 month ago

$SMMT $PLSE Team Genius LFG

Analyst Ratings
Maxim Group Hold Sep 21, 22
HC Wainwright & Co. Neutral May 13, 22
Stephens & Co. Overweight Apr 1, 22
HC Wainwright & Co. Buy Apr 1, 22
HC Wainwright & Co. Buy Feb 10, 22
HC Wainwright & Co. Buy Nov 16, 21
Stephens & Co. Overweight Jul 27, 21
Maxim Group Buy Mar 11, 21
HC Wainwright & Co. Buy Jan 26, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DUGGAN ROBERT W Director Director Dec 12 Buy 9.15 17,999 164,691 36,984,179 12/14/23
DUGGAN ROBERT W Director Director Dec 11 Buy 9.36 90,118 843,504 36,966,180 12/13/23
DUGGAN ROBERT W Director Director Dec 08 Buy 9.54 116,656 1,112,898 36,876,062 12/12/23
DUGGAN ROBERT W Director Director Dec 07 Buy 9.19 74,852 687,890 36,759,406 12/11/23
DUGGAN ROBERT W Director Director Dec 06 Buy 9.06 82,813 750,286 36,684,554 12/08/23
DUGGAN ROBERT W Director Director Dec 06 Option 5.95 9,933 59,101 36,601,741 12/08/23
DUGGAN ROBERT W Director Director Dec 05 Buy 9.34 66,021 616,636 351,565 12/07/23
DUGGAN ROBERT W Director Director Dec 04 Buy 10.38 27,000 280,260 285,544 12/06/23
DUGGAN ROBERT W Director Director Dec 04 Option 10.66 40,347 430,099 36,591,808 12/06/23
DUGGAN ROBERT W Director Director Dec 01 Buy 9.07 45,600 413,592 258,544 12/05/23
DUGGAN ROBERT W Director Director Nov 30 Buy 9.06 152,944 1,385,673 212,944 12/04/23
DUGGAN ROBERT W Director Director Nov 29 Buy 9.33 218,600 2,039,538 60,000 12/01/23
DUGGAN ROBERT W Director Director Nov 29 Option 5.95 1,667 9,919 36,392,861 12/01/23
DUGGAN ROBERT W Director Director Nov 28 Buy 8.98 124,397 1,117,085 36,391,194 11/30/23
DUGGAN ROBERT W Director Director Nov 17 Buy 6.1 20,241 123,470 36,266,797 11/20/23
Danahy Kevin Patrick Chief Executive Offi.. Chief Executive Officer Nov 16 Buy 6.51 5,393 35,108 35,887 11/17/23
Levinson Mitchell E. Chief Strategy Offic.. Chief Strategy Officer Nov 15 Buy 5.91 17,800 105,198 1,039 11/17/23
Zanganeh Mahkam Director Director Nov 13 Option 2.14 76,075 162,800 604,911 11/15/23
DUGGAN ROBERT W Director Director Nov 07 Option 5.95 13,265 78,927 36,246,556 11/09/23
DUGGAN ROBERT W Director Director Aug 25 Option 5.95 1,667 9,919 36,233,291 08/28/23
DUGGAN ROBERT W Director Director Jul 25 Option 5.95 1,667 9,919 36,231,624 07/27/23
DUGGAN ROBERT W Director Director Jul 05 Option 3.41 132,133 450,574 36,229,957 07/07/23
DUGGAN ROBERT W Director Director May 09 Buy 6.51 10,022,937 65,249,320 30,414,661 05/10/23